• 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) Receives Consensus Rating of "Moderate Buy" from Analysts

    Источник: Buzz FX / 17 мар 2025 03:53:16   America/Chicago


    4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) Receives Consensus Rating of "Moderate Buy" from Analysts Written by MarketBeat March 17, 2025 Share Link copied to clipboard. Remove Ads 4D Molecular Therapeutics, Inc.
    Read more...
Опубликовать